[1]
“Assessment of Cytomorphological Features and Risk of Malignancy of Bethesda Category III in Thyroid Cytopathology”, J Pathol Nep, vol. 15, no. 1, pp. 2314–2319, Oct. 2025, doi: 10.3126/jpn.v15i1.81765.